Step by Step


5/11/2021 - Medical Grand Rounds: Evidence based kidney protection in Type 2 Diabetes & beyond





Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Evaluate the prognosis for patients with kidney failure requiring dialysis and ways to improve their outcomes
  • Describe causes of ESKD
  • Explore ways to increase utilization of proven therapies and define additional protective therapies
  • Review ways to prevent kidney failure with RAS blockade and SGLT2 inhibitors in patients with and without T2DM

Suggested Additional Reading & Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

Suggested additional reading:

  1. Mayer JB, Kidney Int 2019;96:489–504 and supplementary appendix
  2. SV Arnold et al. Circulation. 2019;140:618-620.
  3. Bakris GL, et al. N Engl J Med 2020. doi: 10.1056/NEJMoa2025845
  4. Agarwal R, et al. Eur Heart J 2020. In Press
  5. Bakris GL, et al. JAMA 2015;314:884.
  6. Bakris GL, et al. Am J Nephrol 2019;50:333
  7. Perkovic V et al. N Engl J Med 2019;Epub ahead of print doi: 10.1056/NEJMoa1811744
  8. Heerspink HJL. et al. Nephrol Dial Transplant. 2020 Feb 1;35(2):274-282
  9. Wheeler DC. et al. Nephrol Dial Transplant. 2020 DOI 10.1093/ndt/gfaa234

Joint Accreditation Statement
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Vlado Perkovic, MBBS, PhD — Dean of Medicine and Scientia Professor
University of New South Wales, Sydney, Australia
Steering Comm & Presenter/advisory board: Nat Health & Med Res. Council of Australia, Janssen,Abbvie, Bayer, GSK, Boehringer Ingelheim, Lilly, Gilead, Novartis, Novo Nordisk, Retrophin/Travere, Tricida, & Pfizer. Presenter/advisory board: Amgen, Astra Zeneca, Baxter, Durect, Merck, Mitsubishi Tanabe, Mundipharma, Pharmalink, Reata, Relypsa, Roche, Sanofi, & Servier. Board Director: George Clinical Instit, Garvan Instit, Mindgardens Network, Childrens Cancer Instit, Victor Chang Cardiac Res. Inst
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.